Spectral Medical
Toronto
About Spectral Medical
Spectral Medical focuses on the development and commercialization of a treatment for septic shock using its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $60.8M
- Funding stage: IPO
- Last round: Post-IPO Debt (May 2025)
- Ticker: tsx:EDT
- Website: spectraldx.com
- Phone: +1 41-6626-7383
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/spectral-medical-196734 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.